1 Feb 2026
The looming crisis of bedaquiline-resistant tuberculosis and a promising way forwardPublisher siteThe Lancet Infectious Diseases, Tuberculosis Research and Epidemiology
Active, last published 2026
3
H-index
45
Citations
Carole has not officially claimed their profile. If you are Carole, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Carole D. Mitnick will appear here once their profile is updated.
02 · Reach
Publication output and reach
Carole's work has been cited 45 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchPartners In Health, RwandaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works1 Jan 2026Open access
Using Causal Frameworks to Reduce Bias in Observational TB Research: A Comparison of Model-Building ApproachesPublisher siteSSRN Electronic Journal, Advanced Causal Inference Techniques
1 Jan 2025Open access1cites
Bedaquiline, Delamanid, Linezolid and Clofazimine for the Treatment of Rifampicin- and Fluoroquinolone-Resistant Tuberculosis (endTB-Q): A Phase 3, Open-Label, Multicentre, Randomised, Controlled, Stratified, Non-Inferiority TrialPublisher siteSSRN Electronic Journal, Tuberculosis Research and Epidemiology
1 Jan 2025Open access
Effectiveness and Safety of a Shortened Oral Regimen for Rifampicin- or Multidrug-Resistant Tuberculosis in PeruPublisher siteSSRN Electronic Journal, Tuberculosis Research and Epidemiology
10 Dec 2024Open access5cites
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis CohortPublisher siteClinical Infectious Diseases, Tuberculosis Research and Epidemiology
9 May 2024Open access7cites
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosisPublisher siteNature Communications, Tuberculosis Research and Epidemiology
1 Mar 2024Open access32cites
Perspectives from the 2 <sup>nd</sup> International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomesPublisher siteIJTLD OPEN, Tuberculosis Research and Epidemiology
20 Jan 2024Open access
Effectiveness of a bedaquiline, linezolid, clofazimine “core” for multidrug-resistant tuberculosisPublisher siteExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Carole?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you